Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychopharmacology 2004-01, Vol.171 (2), p.229
Hauptverfasser:	Sumnall, H R, Jerome, L, Doblin, R, Mithoefer, M C
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Dopamine - metabolism Hallucinogens - administration & dosage Hallucinogens - adverse effects Humans N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage N-Methyl-3,4-methylenedioxyamphetamine - adverse effects Neurotoxicity Syndromes - etiology Neurotoxicity Syndromes - metabolism Parkinson Disease, Secondary - chemically induced Parkinson Disease, Secondary - metabolism Primates Psychomotor Disorders - chemically induced Psychomotor Disorders - metabolism Species Specificity Street Drugs - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!